佐力药业(300181.SZ)：上半年净利润3.74亿元 同比增长26.16%

Core Viewpoint - Zhaoli Pharmaceutical (300181.SZ) reported a strong performance in the first half of 2025, with significant growth in both revenue and net profit [1] Financial Performance - The company achieved operating revenue of 1.599 billion yuan, representing a year-on-year increase of 11.99% [1] - Net profit attributable to shareholders reached 374 million yuan, reflecting a year-on-year growth of 26.16% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 372 million yuan, with a year-on-year increase of 27.24% [1] - Basic earnings per share were reported at 0.5325 yuan [1]